Showing results (921-930 of 1,530) with videos related to

Sort By:
Pageof 153
Human Heredity|January 1, 1983
Familial resemblance in catecholamine changes to cold stress and maximal exerciseC Bouchard, J Leblanc, J Côté, et al.
International Journal of Cancer|September 15, 1995
Interleukin-6 inhibits the potent stimulatory action of androgens, glucocorticoids and interleukin-1 alpha on apolipoprotein D and GCDFP-15 expression in human breast cancer cellsY Blais, K Sugimoto, M C Carrière, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 1, 1994
Human 17 beta-hydroxysteroid dehydrogenase: overproduction using a baculovirus expression system and characterizationR Breton, F Yang, J Z Jin, et al.
The Prostate|January 1, 1984
Characteristics of the inhibitory effect of chronic treatment with an LHRH agonist on testicular steroidogenesis in the dogY Tremblay, A Bélanger, F Labrie, et al.
Molecular and Cellular Endocrinology|January 1, 1981
Additive inhibitory effects of treatment with an LHRH agonist and an antiandrogen on androgen-dependent tissues in the ratC Séguin, L Cusan, A Bélanger, et al.
Neuroendocrinology|February 1, 1981
Attempts to demonstrate peptide localization and secretion in primary cell cultures of fetal rat hypothalamusF Denizeau, D Dubé, T Antakly, et al.
Fertility and Sterility|May 1, 1983
Gonadotropins and estradiol responses to single intranasal or subcutaneous administration of a luteinizing hormone-releasing hormone agonist in the early follicular phaseA Lemay, A E Metha, G Tolis, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1990
Complete response to combination therapy with an LHRH agonist and flutamide in metastatic male breast cancer: a case reportF Labrie, A Dupont, A Bélanger, et al.
Molecular Oncology|October 2, 2012
Polymorphic variations in the FANCA gene in high-risk non-BRCA1/2 breast cancer individuals from the French Canadian populationNadhir Litim, Yvan Labrie, Sylvie Desjardins, et al.
Menopause (New York, N.Y.)|November 6, 2019
Prevalence of depression and anxiety in women newly diagnosed with vulvovaginal atrophy and dyspareuniaErick Moyneur, Katherine Dea, Leonard R Derogatis, et al.
Pageof 153